P3 Health Partners (PIII) Return on Sales (2021 - 2025)

P3 Health Partners has reported Return on Sales for 5 years, with the latest figure at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 0.03% in Q4 2021, with the low at 0.16% in Q1 2021.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.0% in 2021.
• The largest YoY upside for Return on Sales was 16 bps in 2022 against a maximum downside of 3 bps in 2022.
• P3 Health Partners' Return on Sales stood at 0.03% in 2021, then tumbled by 180 bps to 0.02% in 2022, then soared by 90 bps to 0.0% in 2023, then slumped by 75 bps to 0.0% in 2024, then retreated by 24 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.